ResearcherUniversity of Virginia Health SystemActive in the last 2 years
Sarbajeet Nagdas
Matched on OpenAlex author ID A5030104920; NIH RePORTER profile ID 12315107. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 18
2018: 1 paper · 2019: 1 grant · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer. Co-author DOI 10.3390/biom15070948↗
- Survival benefit associated with screening of patients at elevated risk for pancreatic cancer. Co-author DOI 10.1002/jso.27784↗
- ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer. Co-author DOI 10.1016/j.devcel.2022.04.014↗
- ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer Co-author DOI 10.1101/2020.05.23.112839↗
- CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-17-2283↗
Grants 1
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Todd W. Bauer · 5 shared papers, 2018–2025 · strength 0.78
- Paper PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer. DOI 10.3390/biom15070948↗
- Paper Survival benefit associated with screening of patients at elevated risk for pancreatic cancer. DOI 10.1002/jso.27784↗
- Paper ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer. DOI 10.1016/j.devcel.2022.04.014↗
- William J. Kane · 2 shared papers, 2024–2025 · strength 0.50
- Xiaolong Wei · 1 shared paper, 2025 · strength 0.30
- Turan Tufan · 2 shared papers, 2020–2022 · strength 0.21
- Mazhar Adli · 2 shared papers, 2020–2022 · strength 0.21
- Nabeel M. Bardeesy · 2 shared papers, 2020–2022 · strength 0.21
- Andrew Y. Wang · 1 shared paper, 2024 · strength 0.20
- Allan Tsung · 1 shared paper, 2024 · strength 0.20
- Reid B. Adams · 1 shared paper, 2024 · strength 0.20
- Vanessa M. Shami · 1 shared paper, 2024 · strength 0.20
- David Tsai Ting · 1 shared paper, 2022 · strength 0.12
- William L. Hwang · 1 shared paper, 2022 · strength 0.12
- David F. Kashatus · 1 shared paper, 2022 · strength 0.12
- Harun Öztürk · 1 shared paper, 2022 · strength 0.12
- Craig Lee Slingluff · 1 shared paper, 2018 · strength 0.07
- Alex D. Michaels · 1 shared paper, 2018 · strength 0.07
- Timothy N. J. Bullock · 1 shared paper, 2018 · strength 0.07
- Timothy Eric Newhook · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.